v3.26.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Preferred Stock [Member]
Series B Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 13,982 $ 471 $ 156,689,256 $ (146,699,334) $ 10,004,375
Balance, shares at Dec. 31, 2023 1,398,158 4,706,917      
Common stock issued in connection with warrant exchange [1] $ 200 4,742,043 4,742,243
Common stock issued in connection with warrant exchange, shares [1]   2,000,000      
Return and cancellation of shares in lieu of payroll tax withholding $ (4) (48,406) (48,410)
Return and cancellation of shares in lieu of payroll tax withholding, shares   (34,825)      
Common stock issued in connection with abeyance shares $ 15 (15)
Common stock issued in connection with abeyance shares, shares   150,000      
Stock-based compensation:          
Restricted share units $ 10 985,028 985,038
Restricted share units, shares   97,827      
Options 1,827,528 1,827,528
Net loss (8,979,381) (8,979,381)
Balance at Dec. 31, 2024 $ 13,982 $ 692 164,195,434 (155,678,715) 8,531,393
Balance, shares at Dec. 31, 2024 1,398,158 6,919,919      
Common stock issued in connection with warrant exchange, shares   2,000,000      
Common stock issued in connection with abeyance shares $ 28 (28)
Common stock issued in connection with abeyance shares, shares   283,525      
Stock-based compensation:          
Options 3,325,626 3,325,626
Net loss (14,241,975) (14,241,975)
Exercise of stock options $ 3 41,162 $ 41,165
Exercise of stock options, shares   29,249     29,249
Issuance and sale of common stock, net of issuance costs [2] $ 164 2,700,371 $ 2,700,535
Issuance and sale of common stock, net of issuance costs, shares [2]   1,643,549      
Balance at Dec. 31, 2025 $ 13,982 $ 887 $ 170,262,565 $ (169,920,690) $ 356,744
Balance, shares at Dec. 31, 2025 1,398,158 8,876,242      
[1] Represents the aggregate fair value of 3,351,580 shares of common stock, which includes 2,000,000 shares that were issued at the time of the warrant exchange and 1,351,580 shares that were held in abeyance at the time of the warrant exchange. See Note 6 - Stockholders’ Equity and Note 9 - Fair Value Measurement for additional details.
[2] Represents the gross proceeds of $3,096,250, less issuance costs of $395,715, resulting in net proceeds of $2,700,535. See Note 6 - Stockholders’ Equity for additional details.